Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Neuroimmunology

• Publication date

  1998-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0165-5728(97)00227-0PMID 9610679
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The human toxicity of marijuana

  1994cited by this paper
• Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events.

  1993cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.

  1993cited by this paper
• delta-9-Tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of Bacillus Calmétte-Guérin-activated macrophages.

  1993cited by this paper
• Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins.

  1993cited by this paper
• The immune response to herpes simplex virus

  1993cited by this paper
• Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.

  1992cited by this paper
• Modulation of Interleukin 2 Activity by Δ9-Tetrahydrocannabinol after Stimulation with Concanavalin A, Phytohemagglutinin, or Anti-CD3 Antibody

  1992cited by this paper
• Enhanced Growth of Legionella pneumophila in Tetrahydrocannabinol-Treated Macrophages

  1992cited by this paper
• Δ9-Tetrahydrocannabinol Suppresses Macrophage Extrinsic Antiherpesvirus Activity

  1992cited by this paper
• Cannabis Physiopathology Epidemiology Detection

  1992cited by this paper
• Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages.

  1992cited by this paper
• Δ9-Tetrahydrocannabinol Decreases Cytotoxic T Lymphocyte Activity to Herpes Simplex Virus Type 1-Infected Cells

  1992cited by this paper
• Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones.

  1992cited by this paper
• delta 9-Tetrahydrocannabinol suppresses macrophage extrinsic antiherpesvirus activity.

  1992cited by this paper
• The human toxicity of marijuana

  1992cited by this paper
• Delta 9-tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells.

  1992cited by this paper
• Altered serum immunoglobulin concentration in chronic marijuana smokers.

  1991cited by this paper
• Drugs of Abuse, Immunity, and Immunodeficiency

  1991cited by this paper
• Genital warts do not respond to systemic recombinant interferon alfa-2a treatment during cannabis consumption.

  1991cited by this paper
• Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro.

  1991cited by this paper
• Effects of marijuana on macrophage function.

  1991cited by this paper
• Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection.

  1991cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper
• Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.

  1990cited by this paper
• The Sydney AIDS Project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men.

  1988cited by this paper
• Inhibition of natural killer cell function by marijuana components.

  1988cited by this paper
• Biology of Naegleria spp.

  1988cited by this paper
• Effect of delta 9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig.

  1986cited by this paper
• Δ9-Tetrahydrocannabinol Decreases Alpha/Beta Interferon Response to Herpes Simplex Virus Type 2 in the B6C3F1 Mouse 1

  1986cited by this paper
• Cannabinoid pharmacology.

  1986cited by this paper
• Tetrahydrocannabinol‐Induced Suppression of Macrophage Spreading and Phagocytic Activity In Vitro

  1986cited by this paper
• Marijuana effects on immunity: suppression of human natural killer cell activity of delta-9-tetrahydrocannabinol.

  1986cited by this paper
• delta-9-Tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse.

  1985cited by this paper
• The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses.

  1985influential reference
• Cannabis and health hazards

  1984cited by this paper
• Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. II. In vitro investigation using cultured mouse splenocytes.

  1983cited by this paper
• Effects of Δ9-Tetrahydrocannabinol, Cannabinol and Cannabidiol on the Immune System in Mice

  1983cited by this paper
• Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. I. In vivo investigation of the primary and secondary immune response.

  1983cited by this paper
• Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes

  1980cited by this paper
• Constituents of Cannabis sativa L. XVII. A review of the natural constituents.

  1980cited by this paper
• Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread

  1979cited by this paper
• Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus

  1979cited by this paper
• Hashish smoking and T-lymphocytes

  1978cited by this paper
• Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity.

  1978cited by this paper
• Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus types 1 or 2.

  1977cited by this paper
• Immunosuppressive effects of 8,9-epoxyhexahydrocannabinol (EHHC).

  1977cited by this paper
• Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2.

  1977cited by this paper
• Normal lymphocyte function in the presence of delta‐9‐tetrahydrocannabinol

  1977cited by this paper
• Comparison of antiviral and antitumor activity of activated macrophages.

  1977cited by this paper
• A controlled cycle of tetrahydrocannabinol smoking: T and B cell rosette formation.

  1977cited by this paper
• Marijuana and T Iymphocyte rosettes

  1976cited by this paper
• Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol.

  1976cited by this paper
• VIRAL DISEASES: A SYMPOSIUM

  1976cited by this paper
• Role of Macrophages in Resistance to Murine Cytomegalovirus

  1974cited by this paper
• Inhibition of Cellular Mediated Immunity in Marihuana Smokers

  1974cited by this paper
• Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system

  1974cited by this paper
• Hereditary nephritis.

  1972cited by this paper
• Psychiatric effects of hashish.

  1972cited by this paper
• RESTRICTION OF HERPES SIMPLEX VIRUS BY MACROPHAGES

  1971cited by this paper

• Evidence on the effect of in-utero cannabis exposure in neonates

  2025cites this paper
• Cannabis and the Immune Response: A Comprehensive Review of Therapeutic Potential and Concerns

  2025cites this paper
• Intraperitoneal delivery of cannabidiol (CBD) and Δ9-tetrahydocannabinol (THC) promotes papillomavirus infections in athymic nude mice

  2024cites this paper
• Cannabinoids and triple-negative breast cancer treatment

  2024cites this paper
• The Potential of JWH-133 to Inhibit the TLR4/NF-κB Signaling Pathway in Uterine Ischemia–Reperfusion Injury

  2024cites this paper
• DNA methylation and gene expression of immune cell markers in adolescents with chronic cannabis use: an exploratory study

  2024cites this paper
• Anti-inflammatory effects of cannabinoids

  2023influential citation
• Neurotrophic Factors In Cannabis-Induced Psychosis: An Update.

  2023cites this paper
• Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review

  2022cites this paper
• Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles

  2022cites this paper
• The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases

  2022cites this paper
• Associations between prenatal and postnatal substance exposure and salivary C-reactive protein in early childhood.

  2022cites this paper
• Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase.

  2022cites this paper
• Parkinson's Disease related alterations in cannabinoid transmission.

  2021cites this paper
• Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review

  2021cites this paper
• Coronavirus Disease 2019 (COVID-19) Crisis: Losing Our Immunity When We Need It the Most

  2021cites this paper
• Immunotoxicology

  2020cites this paper
• Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back

  2020cites this paper
• Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects

  2019cites this paper
• Confirmed marijuana use and lymphocyte count in black people living with HIV.

  2019cites this paper
• Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients

  2018cites this paper
• Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach

  2017cites this paper
• Confirmed marijuana use and lymphocyte count in black people living with HIV.

  2017cites this paper
• The Psychoneuroimmunological Influences of Recreational Marijuana

  2017cites this paper
• Velvet Heart: Systemic Fungal Infection Accompanying With Cardiac Involvement and Review Of The Literature

  2017cites this paper
• Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity

  2017cites this paper
• Cannabinoids and autoimmune diseases: A systematic review.

  2016influential citation
• Lifetime marijuana use and sexually transmitted infection history in a sample of Black college students.

  2016cites this paper
• Cannabis and its Effects on the Immune System An extract from Cannabis : A General Survey of its Harmful Effects

  2016cites this paper
• EFFECT OF MARIJUANA ON THE CENTRAL NERVOUS SYSTEM

  2016cites this paper
• Exposure of Adolescent Mice to Delta-9-Tetrahydrocannabinol Induces Long-Lasting Modulation of Pro- and Anti-Inflammatory Cytokines in Hypothalamus and Hippocampus Similar to that Observed for Peripheral Macrophages

  2015cites this paper
• Mobilisation de l'acide arachidonique et sensibilité au peptide ß-amyloïde

  2015cites this paper
• Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study

  2015cites this paper
• CANNABINOIDS Cannabinoids and the immune system

  2015cites this paper
• Evaluation of Some Haematological Parameters Among Marijuana Smokers In Yenagoa, Nigeria.

  2015cites this paper
• CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

  2014cites this paper
• Association between Exposure to HSV1 and Cognitive Functioning in a General Population of Adolescents. The TRAILS Study

  2014cites this paper
• Chronic Δ9-Tetrahydrocannabinol Administration May Not Attenuate Simian Immunodeficiency Virus Disease Progression in Female Rhesus Macaques

  2014cites this paper
• Δ9‐Tetrahydrocannabinol‐induced anti‐inflammatory responses in adolescent mice switch to proinflammatory in adulthood

  2014cites this paper
• CB 2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer ’ s Disease

  2014influential citation
• Oral Tongue Cancers: Pooled Analysis from the INHANCE Association of Marijuana Smoking with Oropharyngeal and Updated version

  2014cites this paper
• Drugs of Abuse and Immuno-Modulation

  2013cites this paper
• CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

  2013influential citation
• CANNABINOIDS DELTA-9-TETRAHYDROCANNABINOL (THC) AND CP55,940 ABLATE SPECIFIC CHEMOKINE AND CYTOKINE INFLAMMATORY RESPONSE IN BV-2 MOUSE MICROGLIAL CELLS ACTIVATED WITH HIV-1 PRO-INFLAMMATORY PROTEIN TAT

  2013cites this paper
• Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells

  2013cites this paper
• Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium

  2013cites this paper
• and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells.

  2013cites this paper
• The Effects of Cannabinoids on Immune Cells, Responses and Diseases

  2012cites this paper
• Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells.

  2012cites this paper
• Inhibition of Apolipoprotein A‐I Gene Expression by Obesity‐Associated Endocannabinoids

  2012cites this paper
• Nerve-Driven Immunity

  2012cites this paper
• Marijuana use and motor vehicle crashes.

  2012cites this paper
• Perinatal Exposure to Δ9-Tetrahydrocannabinol Triggers Profound Defects in T Cell Differentiation and Function in Fetal and Postnatal Stages of Life, Including Decreased Responsiveness to HIV Antigens

  2011cites this paper
• Aus der Medizinischen Klinik und Poliklinik II - Großhadern der Ludwig-Maximilians-Universität München Direktor: Prof. Dr. med. B. Göke Die Rolle des Q63R Polymorphismus im Cannabinoid Rezeptor 2 (CNR2) Gen bei chronisch entzünd- lichen Darmerkrankungen

  2011cites this paper
• The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins

  2011cites this paper
• Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease.

  2011cites this paper
• Cannabinoids and Viral Infections

  2010cites this paper
• Cannabinoids and experimental models of multiple sclerosis.

  2010cites this paper
• Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

  2010cites this paper
• Cannabinoid conditioned reward and aversion: behavioral and neural processes.

  2010cites this paper
• Interleukin-27 Acts as Multifunctional Antitumor Agent in Multiple Myeloma

  2010cites this paper
• Methylenedioxymethamphetamine (‘Ecstasy’)‐induced immunosuppression: a cause for concern?

  2010cites this paper
• Cannabinoids and the immune system: an overview.

  2010cites this paper
• Antibody response to hepatitis B vaccine in substance use disorder patients.

  2010cites this paper
• Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation

  2009cites this paper
• Methylenedioxymethamphetamine (Ecstasy) Decreases Neutrophil Activity and Alters Leukocyte Distribution in Bone Marrow, Spleen and Blood

  2009cites this paper
• Functional CB2 type cannabinoid receptors at CNS synapses.

  2009cites this paper
• Cannabinoid system in the skin – a possible target for future therapies in dermatology

  2009cites this paper
• Cannabinoid Effects on NFkappaB Function in Microglial-Like Cells: Dual Mode of Action

  2009cites this paper
• Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain

  2008cites this paper
• Targeting the Endocannabinoid System in Alzheimer's Disease

  2008cites this paper
• The Cannabinoid Delta-9-tetrahydrocannabinol Mediates Inhibition of Macrophage Chemotaxis to RANTES/CCL5: Linkage to the CB2 Receptor

  2008cites this paper
• Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.

  2008cites this paper
• Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers.

  2008cites this paper
• Cannabinoid Modulation of Chemotaxis of Macrophages and Macrophage-like Cells

  2007cites this paper
• Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

  2007cites this paper
• A Novel Role of Cannabinoids: Implication in the Fever Induced by Bacterial Lipopolysaccharide

  2007cites this paper
• Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis.

  2007cites this paper
• Therapeutic potential of cannabinoid-based drugs.

  2007cites this paper
• Effects of Marijuana on the Lung and Immune Defenses

  2007cites this paper
• Marijuana as therapy for people living with HIV/AIDS: Social and health aspects

  2007cites this paper
• Immune control by endocannabinoids - new mechanisms of neuroprotection?

  2007cites this paper
• Cannabis in New Zealand perceptions of use, users and policy

  2007cites this paper
• Anti‐inflammatory property of the cannabinoid receptor‐2‐selective agonist JWH‐133 in a rodent model of autoimmune uveoretinitis

  2007cites this paper
• Avaliação dos efeitos do N-metil-3,4 metilenodioximetanfetamina (MDMA - Ecstasy) sobre parâmetros comportamentais, neuroendócrinos e de atividade de neutrófilos em camundongos

  2007cites this paper
• WIN55,212-2-Mediated Inhibition of HIV-1 Expression in Microglial Cells: Involvement of Cannabinoid Receptors

  2007influential citation
• HIV‐1 neuropathogenesis: glial mechanisms revealed through substance abuse

  2007cites this paper
• Cannabis use improves retention and virological outcomes in patients treated for hepatitis C

  2006cites this paper
• New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.

  2006cites this paper
• The Endocannabinoid System

  2006cites this paper
• Cannabinoids suppress dendritic cell-induced T helper cell polarization

  2006cites this paper
• Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells

  2006cites this paper
• Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.

  2006cites this paper
• Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy

  2006cites this paper
• Drugs of Abuse, Immune Modulation, and AIDS

  2006cites this paper
• Cannabinoids in medicine: A review of their therapeutic potential.

  2006cites this paper
• [The endocannabinoid system: a new paradigm in the metabolic syndrome treatment].

  2006cites this paper
• O sistema endocanabinóide: novo paradigma no tratamento da síndrome metabólica

  2006cites this paper
• Combined and Independent Effects of Chronic Marijuana Use and HIV on Brain Metabolites

  2006cites this paper
• Delta‐9‐Tetrahydrocannabinol, the Major Psychoactive Component in Marijuana, Inhibits Macrophage Chemotaxis to Acanthamoeba

  2006cites this paper